查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614065

Dydrogesterone市场：按类型、按应用分类 - 2025-2030 年全球预测

Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年地Dydrogesterone市值为5.6786亿美元，预计到2024年将达到6.1812亿美元，复合年增长率为9.45%，预计到2030年将达到10.69亿美元。

Dydrogesterone是一种合成黄体酮激素，广泛用于治疗各种妇科疾病，如月经失调、不孕症、子宫内膜异位症，以及在反覆流产的情况下支持怀孕。对这些健康问题的认识和诊断的提高正在扩大其应用和最终用途的范围。对Dydrogesterone的需求主要是由于其安全性和提供与天然黄体酮类似的治疗结果的功效，使其成为荷尔蒙补充疗法和怀孕支持通讯协定的首选。市场发展很大程度上受到出生率上升、宣导活动活性化和药物开发进步的影响。鼓励医疗保健专业人员开出地屈Dydrogesterone作为其他荷尔蒙疗法的安全替代品也增加了市场潜力。扩大地理可用性对于新兴市场来说是一个机会，因为传统上荷尔蒙疗法的认知度较低。

主要市场统计
基准年[2023] 56786万美元
预计年份 [2024] 61812万美元
预测年份 [2030] 10.69亿美元
复合年增长率（%） 9.45%

然而，市场受到严格的法规环境、学名药的竞争以及患者和从业者担心的潜在副作用的限制。价格敏感性和专利到期问题也阻碍了市场扩张，特别是在医疗保健支出预算有限的新兴市场。创新的重点是改善给药机制和减少副作用，并且正在研究优化配方以及与数位健康平台的集成，以提高患者的依从性和监测。此外，用于开拓的治疗领域的开创性研究可能会扩大市场规模。为了利用这一机会，公司应专注于策略伙伴关係、投资意识计划、扩大开拓市场的销售管道，并加强研究以建立更广泛的适应症。在对提供安全、有效和方便的治疗选择的创新治疗的持续需求的推动下，在监管变化和不断适应消费者偏好的推动下，市场变得越来越活跃。

市场动态：揭示快速发展的地Dydrogesterone市场的关键市场洞察

供需的动态交互作用正在改变地Dydrogesterone市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 老年女性人口的增加和生殖健康问题的蔓延
    • 政府对妇女健康的支持政策
    • 改善各国的医疗基础设施
  • 市场限制因素
    • 生产地Dydrogesterone的高成本
  • 市场机会
    • Dydrogesterone仿製学名药核准数量增加
    • 市场参与企业增加投资和业务扩张
  • 市场挑战
    • 严格的地Dydrogesterone药物核准流程

波特的五力：驾驭地Dydrogesterone市场的策略工具

波特的五力架构是了解地Dydrogesterone市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解地Dydrogesterone市场的外部影响

外部宏观环境因素在塑造地Dydrogesterone市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解地Dydrogesterone市场的竞争格局

对地Dydrogesterone市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵地Dydrogesterone市场供应商的绩效评估

FPNV 定位矩阵是评估地Dydrogesterone市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了地Dydrogesterone市场的成功之路

Dydrogesterone市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 女性人口老化加剧和生殖健康问题普遍存在
      • 支持妇女健康的政府政策
      • 改善整个经济领域的医疗基础设施
    • 抑制因素
      • 生产地Dydrogesterone的成本很高。
    • 机会
      • 学名药核准增加
      • 市场参与企业增加投资和扩张
    • 任务
      • 与地Dydrogesterone药物相关的严格监管核准流程
  • 市场区隔分析
    • 类型：DydrogesteroneD6在高精度分析和临床试验的优势
    • 用途：Dydrogesterone在妇科疾病症状缓解和荷尔蒙调节的重要应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Dydrogesterone市场：依类型

  • DydrogesteroneD5
  • DydrogesteroneD6

第七章地Dydrogesterone市场：依应用分类

  • 妇科疾病
  • 不孕症

第八章美洲地Dydrogesterone市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区地Dydrogesterone市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲地Dydrogesterone市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Theramex 宣布同意从 Viatris 收购 Duphaston 和 Femoston 的欧洲权利
    • Aurisco 奥昔酮（Dydrogesterone）获得中国首个学名药核准
    • 美国製药大厂申请发布改良版药物，用于治疗子宫内膜异位症引起的骨盆腔疼痛
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Adalvo Limited
  • Alembic Pharmaceuticals Limited
  • Axios Research
  • Clearsynth
  • Dr. D Pharma
  • Gufic Group
  • H & Care Incorp
  • Jagsonpal Pharmaceuticals Ltd.
  • Mankind Pharma Limited
  • Medley Pharmaceuticals Ltd.
  • Merck KGaA
  • Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • Santa Cruz Biotechnology, Inc.
  • Simson Pharma Limited
  • Solitaire Pharmacia Private Limited
  • Somacare
  • Synokem Pharmaceuticals Ltd.
  • Taj Pharmaceuticals Limited
  • Theramex
  • TLC Pharmaceutical Standards Ltd.
  • Viatris Inc.
  • VIVAN Life Sciences
  • Zuventus Healthcare Limited
Product Code: MRR-144C638C9216

The Dydrogesterone Market was valued at USD 567.86 million in 2023, expected to reach USD 618.12 million in 2024, and is projected to grow at a CAGR of 9.45%, to USD 1,069.00 million by 2030.

Dydrogesterone is a synthetic progesterone hormone widely used in the treatment of various gynecological conditions such as menstrual disorders, infertility, endometriosis, and to support pregnancy in cases of recurrent miscarriage. Increasing awareness and diagnosis of these health issues are expanding its application and end-use scope. The necessity of dydrogesterone is primarily driven by its safety profile and effectiveness in delivering therapeutic outcomes similar to natural progesterone, making it the preferred choice in hormone replacement therapies and pregnancy support protocols. Market growth is significantly influenced by rising fertility rates, increased awareness campaigns, and advancements in pharmaceutical development. The encouragement of healthcare professionals to prescribe dydrogesterone as a safe alternative to other hormone therapy options further cues its market potential. Opportunities lie in the expanding geographical availability in emerging markets where awareness of hormonal therapies was traditionally low.

KEY MARKET STATISTICS
Base Year [2023] USD 567.86 million
Estimated Year [2024] USD 618.12 million
Forecast Year [2030] USD 1,069.00 million
CAGR (%) 9.45%

However, the market is constrained by stringent regulatory environments, generic competition, and potential side effects that are a concern among patients and practitioners. Price sensitivity and patent expiry challenges also hamper market expansion, particularly in developing regions with budget constraints on healthcare spending. Innovations are focused on improving delivery mechanisms and reducing side effects, with ongoing research into optimized formulations and integration with digital health platforms for better patient compliance and monitoring. Additionally, pioneering studies around its use in unexplored therapeutic areas could enhance the market reach. To capitalize on opportunities, companies should focus on strategic partnerships, investing in awareness programs, expanding their distribution channels in underpenetrated markets, and enhancing research to establish broader indications for dydrogesterone use. The market is progressively dynamic, requiring continuous adaptability to regulatory changes and consumer preferences, driven by ongoing demand for innovative therapies that provide safe, effective, and convenient treatment options.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dydrogesterone Market

The Dydrogesterone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing elderly female population and prevalence of reproductive health issues
    • Supportive government policies for women's health
    • Improved healthcare infrastructure across economies
  • Market Restraints
    • High costs associated with dydrogesterone production
  • Market Opportunities
    • Rising approval of generic dydrogesterone drugs
    • Growing investment and expansion by market players
  • Market Challenges
    • Stringent regulatory approval processes associated with dydrogesterone drugs

Porter's Five Forces: A Strategic Tool for Navigating the Dydrogesterone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dydrogesterone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dydrogesterone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dydrogesterone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dydrogesterone Market

A detailed market share analysis in the Dydrogesterone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dydrogesterone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dydrogesterone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dydrogesterone Market

A strategic analysis of the Dydrogesterone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dydrogesterone D5 and Dydrogesterone D6.
  • Based on Application, market is studied across Gynecological Diseases and Infertility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
      • 5.1.1.2. Supportive government policies for women's health
      • 5.1.1.3. Improved healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with dydrogesterone production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising approval of generic dydrogesterone drugs
      • 5.1.3.2. Growing investment and expansion by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • 5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dydrogesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Dydrogesterone D5
  • 6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application

  • 7.1. Introduction
  • 7.2. Gynecological Diseases
  • 7.3. Infertility

8. Americas Dydrogesterone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dydrogesterone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
    • 11.3.2. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
    • 11.3.3. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adalvo Limited
  • 3. Alembic Pharmaceuticals Limited
  • 4. Axios Research
  • 5. Clearsynth
  • 6. Dr. D Pharma
  • 7. Gufic Group
  • 8. H & Care Incorp
  • 9. Jagsonpal Pharmaceuticals Ltd.
  • 10. Mankind Pharma Limited
  • 11. Medley Pharmaceuticals Ltd.
  • 12. Merck KGaA
  • 13. Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • 14. Santa Cruz Biotechnology, Inc.
  • 15. Simson Pharma Limited
  • 16. Solitaire Pharmacia Private Limited
  • 17. Somacare
  • 18. Synokem Pharmaceuticals Ltd.
  • 19. Taj Pharmaceuticals Limited
  • 20. Theramex
  • 21. TLC Pharmaceutical Standards Ltd.
  • 22. Viatris Inc.
  • 23. VIVAN Life Sciences
  • 24. Zuventus Healthcare Limited

LIST OF FIGURES

  • FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DYDROGESTERONE MARKET DYNAMICS
  • TABLE 7. GLOBAL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023